Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

(MedPage Today) -- FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt...